Literature DB >> 2930589

Activity of N-(2-hydroxypropyl)methacrylamide copolymers containing daunomycin against a rat tumour model.

J Cassidy1, R Duncan, G J Morrison, J Strohalm, D Plocova, J Kopecek, S B Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2930589     DOI： 10.1016/0006-2952(89)90274-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

Review 1.  Pharmacology and toxicology of novel drug delivery systems. Regulatory issues.

Authors:  J Weissinger
Journal:  Drug Saf       Date:  1990       Impact factor: 5.606

Review 2.  Fabricated Elastin.

Authors:  Behnaz Aghaei-Ghareh-Bolagh; Edwin P Brackenreg; Matti A Hiob; Pearl Lee; Giselle C Yeo; Anthony S Weiss
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

3.  A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.

Authors:  Gene L Bidwell; Aisha N Davis; Izabela Fokt; Waldemar Priebe; Drazen Raucher
Journal:  Invest New Drugs       Date:  2007-05-05       Impact factor: 3.850

4.  Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.

Authors:  T K Yeung; J W Hopewell; R H Simmonds; L W Seymour; R Duncan; O Bellini; M Grandi; F Spreafico; J Strohalm; K Ulbrich
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 5.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

6.  Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier.

Authors:  Iqbal Massodi; Shama Moktan; Aruna Rawat; Gene L Bidwell; Drazen Raucher
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

7.  Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative.

Authors:  Leslie Walker; Eddie Perkins; Felix Kratz; Drazen Raucher
Journal:  Int J Pharm       Date:  2012-07-28       Impact factor: 5.875

8.  N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

Authors:  L W Seymour; K Ulbrich; S R Wedge; I C Hume; J Strohalm; R Duncan
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

9.  Comparison of the liver subcellular distribution of free daunomycin and that bound to galactosamine targeted N-(2-hydroxypropyl)methacrylamide copolymers, following intravenous administration in the rat.

Authors:  S R Wedge; R Duncan; P Kopeckova
Journal:  Br J Cancer       Date:  1991-04       Impact factor: 7.640

10.  Tumour tropism and anti-cancer efficacy of polymer-based doxorubicin prodrugs in the treatment of subcutaneous murine B16F10 melanoma.

Authors:  L W Seymour; K Ulbrich; P S Steyger; M Brereton; V Subr; J Strohalm; R Duncan
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.